Histamine boosting drug improves memory accuracy

A drug that increases histamine levels in the brain can enhance memory retrieval by around 10 per cent, according to a small study. Researchers tested the narcolepsy treatment pitolisant on volunteers and found improved brain connectivity and accuracy.

The study involved 60 participants who received either pitolisant or a placebo. Those given the drug showed stronger connections between histamine-producing brain areas and the hippocampus during memory tasks.

Participants on pitolisant performed 11 per cent better at recalling information learned in an MRI scanner. Michael Colwell of the University of Oxford said the drug appears to heighten alertness to new stimuli.

Experts caution against using pitolisant as a cognitive enhancer. It may disrupt sleep, which could harm long-term memory, Colwell noted.

The findings were published in Nature Communications and confirm results seen in animal studies. They could inform future treatments for brain conditions involving histamine receptors.

Verwandte Artikel

Scientist in lab studying mouse with DNA and brain inflammation overlays representing Alzheimer’s drug research.
Bild generiert von KI

Experimental drug reduced DNA damage and inflammation in an Alzheimer’s mouse model, King’s College London says

Von KI berichtet Bild generiert von KI Fakten geprüft

Scientists at King’s College London report that an experimental compound, KCL-286, repaired markers of DNA damage and lowered brain inflammation in a mouse model of Alzheimer’s disease. The team says the drug—originally developed for spinal cord injury—has already completed Phase 1 safety and tolerability testing in humans, which could speed plans for further clinical studies.

A new study shows that healthy older adults experienced real improvements in memory, physical function, and stress levels after taking placebo pills for three weeks. The benefits occurred even when participants knew the pills were inactive. Researchers at Università Cattolica in Milan conducted the trial.

Von KI berichtet

Researchers at Cold Spring Harbor Laboratory have found that blocking the protein PTP1B improves memory and boosts plaque clearance in mouse models of Alzheimer's disease. The discovery links the protein to brain immune function and metabolic risks like diabetes and obesity. The team aims to develop inhibitors for potential human treatments.

Researchers at Texas A&M University have developed a nasal spray that appears to reverse aspects of brain aging after just two doses. The treatment reduced inflammation and restored memory function in models for months afterward. The findings were published in the Journal of Extracellular Vesicles.

Von KI berichtet

A widely studied anti-aging treatment triggered significant brain damage in mice, according to new research from the University of Connecticut. The drug combination dasatinib plus quercetin caused myelin loss and changes resembling those seen in multiple sclerosis. The findings raise questions about its use in longevity studies and off-label therapies.

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen